Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -154,766 | -100,362 | -49,525 | -152,631 | -109,845 |
| Depreciation Amortization | -9,612 | -6,383 | -3,036 | -8,571 | -6,052 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -924 | N/A |
| Other Working Capital | 3,915 | -1,820 | -4,917 | 7,819 | 4,108 |
| Other Operating Activity | 25,649 | 17,191 | 8,634 | 29,483 | 21,273 |
| Operating Cash Flow | $-134,814 | $-91,374 | $-48,844 | $-124,824 | $-90,516 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,535 | -52,070 | -95,253 | 15,725 | -26,486 |
| PPE Investments | -100 | -100 | -84 | -168 | -152 |
| Investing Cash Flow | $-6,635 | $-52,170 | $-95,337 | $15,557 | $-26,638 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 153,611 | 151,409 | 148,369 | 94,783 | 94,092 |
| Financing Cash Flow | $153,611 | $151,409 | $148,369 | $94,783 | $94,092 |
| Beginning Cash Position | 37,318 | 37,318 | 37,318 | 51,802 | 51,802 |
| End Cash Position | 49,480 | 45,183 | 41,506 | 37,318 | 28,740 |
| Net Cash Flow | $12,162 | $7,865 | $4,188 | $-14,484 | $-23,062 |
| Free Cash Flow | |||||
| Operating Cash Flow | -134,814 | -91,374 | -48,844 | -124,824 | -90,516 |
| Capital Expenditure | -100 | -100 | -84 | -168 | -152 |
| Free Cash Flow | -134,914 | -91,474 | -48,928 | -124,992 | -90,668 |